Purple Biotech Overview

  • Year Founded
  • 1968

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • PPBT-L

Stock Symbol

  • Investments
  • 4

Purple Biotech General Information

Description

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Contact Information

Formerly Known As
Kitov Pharmaceuticals, Kitov Pharmaceuticals Holdings Ltd., Kitov Pharma Ltd.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 4 Oppenheimer Street
  • Science Park
  • Rehovot 7670104
  • Israel
+972
Primary Industry
Drug Discovery
Stock Exchange
TAE
Vertical(s)
Corporate Office
  • 4 Oppenheimer Street
  • Science Park
  • Rehovot 7670104
  • Israel
+972

Purple Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Purple Biotech Stock Performance

As of 20-Oct-2026, Purple Biotech’s current market cap is $10.5M with 3.25B shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.5M 3.25B 94.9K -$0.10

Purple Biotech Financials Summary

As of 30-Jun-2026, Purple Biotech has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (437) (3,775) 4,921 5,618
Revenue 0 0 0 0
EBITDA (24,502) (26,477) (7,312) (20,198)
Net Income (24,493) (26,386) (7,240) (19,880)
Total Assets 14,166 17,572 37,038 44,302
Total Debt 134 244 183 351
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Purple Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Purple Biotech‘s full profile, request access.

Request a free trial

Purple Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmac
Drug Discovery
Rehovot, Israel
10 As of 2025

Lund, Sweden
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Purple Biotech Competitors (5)

One of Purple Biotech’s 5 competitors is BioInvent International, a Formerly VC-backed company based in Lund, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioInvent International Formerly VC-backed Lund, Sweden
Ayala Pharmaceuticals Corporation Wilmington, DE
Astellas Pharma Corporation Tokyo, Japan
Zentalis Pharmaceuticals Formerly VC-backed San Diego, CA
Seagen Formerly VC-backed Bothell, WA
You’re viewing 5 of 5 competitors. Get the full list »

Purple Biotech Patents

Purple Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019008583-A1 Celecoxib and amlodipine formulation and method of making the same Inactive 06-Jul-2017
WO-2011100659-A2 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Inactive 12-Feb-2010
WO-2011100659-A3 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Inactive 12-Feb-2010
US-20110136793-A1 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Active 28-May-2008
US-20160058744-A1 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs Active 28-May-2008 A61K31/4422
To view Purple Biotech’s complete patent history, request access »

Purple Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Purple Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Purple Biotech‘s full profile, request access.

Request a free trial

Purple Biotech Investments & Acquisitions (4)

Purple Biotech’s most recent deal was a Merger/Acquisition with Immunorizon. The deal was made on 15-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunorizon 15-Feb-2023 Merger/Acquisition Other Healthcare Technology Systems
FameWave 08-Jan-2020 Merger/Acquisition Drug Discovery
TyrNovo 06-Oct-2017 Secondary Transaction - Private Drug Discovery
TyrNovo 06-Oct-2017 Merger/Acquisition Drug Discovery
To view Purple Biotech’s complete investments and acquisitions history, request access »

Purple Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Purple Biotech’s complete esg history, request access »

Purple Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
TyrNovo Herzliya, Israel 2005

Purple Biotech FAQs

  • When was Purple Biotech founded?

    Purple Biotech was founded in 1968.

  • Where is Purple Biotech headquartered?

    Purple Biotech is headquartered in Rehovot, Israel.

  • What is the size of Purple Biotech?

    Purple Biotech has 10 total employees.

  • What industry is Purple Biotech in?

    Purple Biotech’s primary industry is Drug Discovery.

  • Is Purple Biotech a private or public company?

    Purple Biotech is a Public company.

  • What is Purple Biotech’s stock symbol?

    The ticker symbol for Purple Biotech is PPBT-L.

  • What is the current market cap of Purple Biotech?

    The current market capitalization of Purple Biotech is $10.5M.

  • Who are Purple Biotech’s competitors?

    BioInvent International, Ayala Pharmaceuticals, Astellas Pharma, Zentalis Pharmaceuticals, and Seagen are competitors of Purple Biotech.

  • What is Purple Biotech’s annual earnings per share (EPS)?

    Purple Biotech’s EPS for 12 months was -$0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process